![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Company type
Developer of a drug-eluting stent for the treatment of vascular bifurcations.Funding rounds
Series D USD 32,000,000
USD 32,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
InterWest Partners | Diversified venture capital firm based in Silicon Valley. | Led the round. | |
|
US Venture Partners. (USVP) | Silicon Valley venture capital firm. | Led the round. | |
|
Bio-Star Private Equity Fund LLC |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
N/A
Date N/A.
| Investor | Profile | Country | |
|---|---|---|---|
|
Rock Creek Capital | One of the largest woman and diverse-owned global investment firms. |
Investment activity status
Active investor